Finally, it has been also reported that a proteasome inhibitor, bortezomib showed its anti-tumor efficacy by hyperactivating Hsp60 and HSP90 expression on the surface of cancer cells leading to phagocytosis in murine model of ovarian cancer [227]. The gene discussed is HSP90AB1; the disease is neoplasm.